Because one burns existing body fat as a fuel source and the other focuses on preventing your body from absorbing more fat from your diet, both supplements work in cohesion, attacking the problem from both angles
Gradual Fat Loss (Less Targeted than Tesamorelin) : Sermorelin supports gentle fat loss (including visceral fat) over time, though not as specific or fast-acting as Tesamorelin in clinical trials
Going far above three grams daily has not shown better outcomes and raises side effect risk
Verdict: Insufficient evidence DSIP has not been shown to improve training recovery outcomes directly [4][6]
It is also worth mentioning that the selection of women for our study was carried out by convenience since the participants were part of another follow-up study, which affected the studys sample size, which may be these limitations for the interpretation of our results
Time-to-onset analysis of NAEs associated with GLP-1 RAs The median time-to-onset of NAEs for all GLP-1 RAs was 31 days (interquartile range [IQR] 7123), with 46.25% occurring within the first 30 days of treatment initiation (Table S6, Figure S2)